📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease. (2024)

First Author: Thomas T

Attributed to: The TWO Study: A Phase II trial of regulatory T cells in renal transplantation - can we achieve sirolimus monotherapy? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41590-024-01994-8

PubMed Identifier: 39438660

Publication URI: http://europepmc.org/abstract/MED/39438660

Type: Journal Article/Review

Volume: 25

Parent Publication: Nature immunology

Issue: 11

ISSN: 1529-2908